Cited by 1,435Pancreatic function and diabetesDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Banting Lecture 2001

McGarry, J. Denis·2002·Diabetes

Abstract

Readers of this journal do not need to be reminded of the explosive increase in obesity/type 2 diabetes syndromes and their attendant staggering public health costs that are currently afflicting developed countries. Because of this alarming development and what it portends for the future if left unchecked, the American Diabetes Association, together with its counterparts around the world, as well as the World Health Organization, are faced with the daunting challenge of finding answers to two huge questions. First, what is the pathophysiological basis for these disorders? Second, why is their rate of appearance accelerating so rapidly at this particular juncture of human history, and what, if anything, can we do to intervene? The primary focus of this lecture will be on the first of these issues. I want to emphasize at the outset that I do not plan to dwell exclusively on our own studies in this area. Instead, I shall try to incorporate recent developments from a variety of other laboratories working in the field. Although these will of necessity have to be highly selective, I hope that collectively they will illustrate how we have come to a relatively new and exciting way of thinking about the etiology of type 2 diabetes. It has been said in literary circles that James Joyce’s Ulysses is probably the most frequently opened and least read book that has ever been published. In a similar vein, I sometimes think that the question of what causes type 2 diabetes might be one of the most frequently asked and least satisfactorily answered in the history of diabetes research. This is not meant to be an arrogant statement, nor indeed does it imply that I have a magical solution to the question at hand. Rather, it simply reflects the fact that at the dawn of …

Integrity signals

Registry

Crossref · 10.2337/diabetes.51.1.7

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • One common feature of diverse insulin-resistant states is an elevation in nonesterified fatty acids.

    “One common feature of diverse insulin-resistant states is an elevation in nonesterified fatty acids (11).”
  • Elevated circulating lipid and inflammatory cytokines usually occur prior to development of hyperinsulinemia and hyperglycemia during progression of type 2 diabetes.

    “Although many studies demonstrated the effect of hyperglycemia on increased generation of ROS and mitochondrial fission in a variety of cell types (26, 48), elevated circulating lipid and inflammatory cytokines usually occur prior to the development of hyperinsulinemia and hyperglycemia during the progression of type 2 diabetes (27, 38).”
  • Increased intramyocellular fat content and fatty acid metabolites have a pivotal role in the development of skeletal muscle insulin resistance.

    “an increased intramyocellar fat content and fatty acid metabolites have been shown to play a pivotal role in the development of insulin resistance in skeletal muscle [11–15].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [12]

  • Dysregulation of fatty acid metabolism has a central role in the development of insulin resistance in skeletal muscle.

    “Dysregulation of fatty acid metabolism plays a pivotal role in the pathogenesis of insulin resistance in skeletal muscle.”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [12]

  • Chronically elevated plasma free fatty acid levels cause insulin resistance in skeletal muscle.

    “It is well established that chronically elevated plasma FFA levels cause insulin resistance in skeletal muscle [1, 12, 14, 62–65].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [12]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McGarry, J. D.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
McGarry, J. Denis
Venue
Diabetes
Published
2002-01-01
Volume
51
Issue
1
Pages
7-18
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2430143578
Cited by
1,435
References
96
Citations by year
2026: 10 · 2025: 15 · 2024: 27 · 2023: 30 · 2022: 39 · 2021: 30 · 2020: 38 · 2019: 24 · 2018: 26 · 2017: 35 · 2016: 52 · 2015: 61 · 2014: 60 · 2013: 84 · 2012: 86
FWCI
93.35
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, obesity, pathophysiology, disease acceleration, diabetes prevention
MeSH terms
Insulin Secretion, Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Glucose, Homeostasis, Humans, Insulin, Islets of Langerhans, Models, Biological, Obesity, Triglycerides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review